These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines. Joffe S JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069 [No Abstract] [Full Text] [Related]
5. Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical? Dal-Ré R; Caplan AL Clin Microbiol Infect; 2021 Nov; 27(11):1565-1567. PubMed ID: 34375757 [No Abstract] [Full Text] [Related]
6. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
8. Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs. Sisa I; Noblecilla E; Orozco F Lancet; 2021 Mar; 397(10277):878. PubMed ID: 33617776 [No Abstract] [Full Text] [Related]
9. Placebo-controlled trials of Covid-19 vaccines - Are they still ethical? Ortiz-Millán G Indian J Med Ethics; 2021; VI(2):1-8. PubMed ID: 33908358 [TBL] [Abstract][Full Text] [Related]
10. Placebo in new Covid-19 vaccine trials: data quality prioritised over participants' rights. Srinivasan S Indian J Med Ethics; 2021; VI(2):1-6. PubMed ID: 33908351 [TBL] [Abstract][Full Text] [Related]
11. "No" to placebo-controlled trials of Covid-19 vaccines. Ahmad A; Dhrolia MF Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356 [TBL] [Abstract][Full Text] [Related]
12. Placebo use in vaccine trials: recommendations of a WHO expert panel. Rid A; Saxena A; Baqui AH; Bhan A; Bines J; Bouesseau MC; Caplan A; Colgrove J; Dhai A; Gomez-Diaz R; Green SK; Kang G; Lagos R; Loh P; London AJ; Mulholland K; Neels P; Pitisuttithum P; Sarr SC; Selgelid M; Sheehan M; Smith PG Vaccine; 2014 Aug; 32(37):4708-12. PubMed ID: 24768580 [TBL] [Abstract][Full Text] [Related]
13. Problematic Covid-19 vaccine trials in times of vaccine nationalism. Ravinetto R Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccine trial ethics once we have efficacious vaccines. Wendler D; Ochoa J; Millum J; Grady C; Taylor HA Science; 2020 Dec; 370(6522):1277-1279. PubMed ID: 33273060 [No Abstract] [Full Text] [Related]
15. Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials. Mehrotra DV; Janes HE; Fleming TR; Annunziato PW; Neuzil KM; Carpp LN; Benkeser D; Brown ER; Carone M; Cho I; Donnell D; Fay MP; Fong Y; Han S; Hirsch I; Huang Y; Huang Y; Hyrien O; Juraska M; Luedtke A; Nason M; Vandebosch A; Zhou H; Cohen MS; Corey L; Hartzel J; Follmann D; Gilbert PB Ann Intern Med; 2021 Feb; 174(2):221-228. PubMed ID: 33090877 [TBL] [Abstract][Full Text] [Related]
16. Testing vaccines in the time of Covid: The changing landscape. Cash RA Indian J Med Ethics; 2021; VI(2):1-4. PubMed ID: 33908357 [TBL] [Abstract][Full Text] [Related]
17. Trials for second generation Covid-19 vaccines: Revisiting the debate over placebo use in developing country clinical trials. Lurie P Indian J Med Ethics; 2021; VI(2):1-10. PubMed ID: 33908352 [TBL] [Abstract][Full Text] [Related]
18. Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. Haas JW; Bender FL; Ballou S; Kelley JM; Wilhelm M; Miller FG; Rief W; Kaptchuk TJ JAMA Netw Open; 2022 Jan; 5(1):e2143955. PubMed ID: 35040967 [TBL] [Abstract][Full Text] [Related]
19. Placebo control in Covid-19 trials: A missed opportunity for international guidance. Wiesing U; Ehni HJ Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908353 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccines: concerns beyond protective efficacy and safety. Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]